INCY vs PACS · P/E 14, rev $5.14B vs P/E 23, rev $5.29B
Incyte Corporation (INCY) versus PACS Group, Inc. (PACS) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
PACS Group, Inc. (PACS) is a medical care facilities company listed on NYSE.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported PACS revenue for 2025-12-31 was $5.29B. Net income was $191.5M. Revenue was up 29.3% from 2024-12-31 to 2025-12-31. PACS currently screens at market cap $5.58B and trailing P/E 22.7.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. PACS currently screens at market cap $5.58B and trailing P/E 22.7.
Not investment advice. Open the INCY and PACS stock pages for the full models.
Not investment advice.